Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Psychiatry & Neuroscience

• Publication date

  2018-02-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1503/jpn.170053PMID 29402374PMCID PMC5915240
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mendelian randomisation for nutritional psychiatry.

  2019cited by this paper
• High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia

  2017cited by this paper
• The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis

  2017cited by this paper
• Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia risk.

  2016cited by this paper
• Genetic analysis of the glyoxalase system in schizophrenia.

  2015cited by this paper
• Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia.

  2015cited by this paper
• Schizophrenia in 2020: Trends in diagnosis and therapy

  2015cited by this paper
• Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian randomization analysis

  2015cited by this paper
• Biological Insights From 108 Schizophrenia-Associated Genetic Loci

  2014cited by this paper
• Mendelian randomization in health research: Using appropriate genetic variants and avoiding biased estimates☆

  2014cited by this paper
• Mendelian randomization: genetic anchors for causal inference in epidemiological studies

  2014cited by this paper
• DNA methylation changes in the postmortem dorsolateral prefrontal cortex of patients with schizophrenia

  2014cited by this paper
• Replication of enhanced carbonyl stress in a subpopulation of schizophrenia

  2014cited by this paper
• Clinical features of schizophrenia with enhanced carbonyl stress.

  2014cited by this paper
• Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophrenia.

  2014cited by this paper
• Aberrant DNA Methylation of Blood in Schizophrenia by Adjusting for Estimated Cellular Proportions

  2014cited by this paper
• Meta-analyses of Blood Homocysteine Levels for Gender and Genetic Association Studies of the MTHFR C677T Polymorphism in Schizophrenia

  2014cited by this paper
• DNA Methylation Signatures of Peripheral Leukocytes in Schizophrenia

  2012cited by this paper
• Genome-Wide Association Study of Schizophrenia in Japanese Population

  2011cited by this paper
• No association between the PCM1 gene and schizophrenia: a multi-center case-control study and a meta-analysis.

  2011cited by this paper
• Genome-wide association study of schizophrenia in a Japanese population.

  2011cited by this paper
• Enhanced carbonyl stress in a subpopulation of schizophrenia.

  2010cited by this paper
• One-carbon metabolism and schizophrenia: current challenges and future directions.

  2009cited by this paper
• Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations.

  2009influential reference
• Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study.

  2007cited by this paper
• The Role of One‐Carbon Metabolism in Schizophrenia and Depression

  2007cited by this paper
• Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia.

  2006cited by this paper
• Vitamin B6 Versus Mianserin and Placebo in Acute Neuroleptic-induced Akathisia: A Randomized, Double-blind, Controlled Study

  2006cited by this paper
• A Systematic Review of the Prevalence of Schizophrenia

  2005cited by this paper
• Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study.

  2004cited by this paper
• Fasting and post-methionine loading concentrations of homocysteine, vitamin B2, and vitamin B6 in patients on antiepileptic drugs.

  2003cited by this paper
• Vitamin B6 as add-on treatment in chronic schizophrenic and schizoaffective patients: a double-blind, placebo-controlled study.

  2002cited by this paper
• Lithium-Induced Tremor Treated with Vitamin B6: A Preliminary Case Series

  2002cited by this paper
• Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.

  1999cited by this paper
• Movement disorders and psychotic symptoms treated with pyridoxine: a case report.

  1998cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Pyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patient.

  1990cited by this paper
• Negative findings with megavitamins in schizophrenic patients: preliminary report.

  1977cited by this paper
• Potentiation of Therapeutic Effects of Nicotinic Acid by Pyridoxine in Chronic Schizophrenics *

  1973cited by this paper
• Pyridoxine and Schizophrenia

  1973cited by this paper

• Metabolic Mechanisms in Electroconvulsive Therapy for Schizophrenia: Role, Potential and Future Directions.

  2026cites this paper
• DNMT gene expression in peripheral leukocytes in schizophrenia and correlations with one-carbon metabolites: folate, total homocysteine, and vitamin B6

  2026cites this paper
• Causal relationship between B vitamins and neuropsychiatric disorders: A systematic review and meta-analysis.

  2025cites this paper
• Current state of nutritional psychiatry: A scoping review of randomized controlled trials

  2025cites this paper
• Oxidative Stress in Schizophrenia: Relation to Neurochemical Pathogenetic Hypotheses

  2024cites this paper
• 7,8-Dihydroxyflavone is a direct inhibitor of pyridoxal phosphatase

  2024cites this paper
• 7,8-Dihydroxyflavone is a direct inhibitor of human and murine pyridoxal phosphatase

  2024cites this paper
• Current evidence for adjunct pyridoxine (vitamin B6) for the treatment of behavioral adverse effects associated with levetiracetam: A systematic review.

  2023cites this paper
• Gut–brain axis volatile organic compounds derived from breath distinguish between schizophrenia and major depressive disorder

  2023cites this paper
• Schizophrenia and co-morbidity risk: Evidence from a data driven phenomewide association study.

  2023cites this paper
• Consensus on potential biomarkers developed for use in clinical tests for schizophrenia

  2022cites this paper
• Biological hypotheses, risk factors, and biomarkers of schizophrenia.

  2022cites this paper
• Halting the Metabolic Complications of Antipsychotic Medication in Patients with a First Episode of Psychosis: How Far Can We Go with the Mediterranean Diet? A Pilot Study

  2022cites this paper
• Applications of Mendelian randomization in psychiatry: a comprehensive systematic review

  2022cites this paper
• The efficacy of nutritional supplements for the adjunctive treatment of schizophrenia in adults: A systematic review and network meta-analysis.

  2022cites this paper
• Role of glyoxalase 1 in methylglyoxal detoxification–the broad player of psychiatric disorders

  2021cites this paper
• Inborn errors in the vitamin B6 salvage enzymes associated with neonatal epileptic encephalopathy and other pathologies.

  2021cites this paper
• Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives

  2021cites this paper
• Unconvincing evidence for peripheral biomarkers in major mental disorders

  2021cites this paper
• Vitamin B6 deficiency hyperactivates the noradrenergic system, leading to social deficits and cognitive impairment

  2021cites this paper
• Combined glyoxalase 1 dysfunction and vitamin B6 deficiency in a schizophrenia model system causes mitochondrial dysfunction in the prefrontal cortex

  2021cites this paper
• Mendelian Randomization for Nutritional Psychiatry

  2020cites this paper
• Neuroimaging studies within Cognitive Genetics Collaborative Research Organization aiming to replicate and extend works of ENIGMA

  2020cites this paper
• Variable number tandem repeats mediate the expression of proximal genes

  2020cites this paper
• Association between serum folate levels and schizophrenia based on sex

  2020cites this paper
• Nutritional psychiatry in the treatment of psychotic disorders: Current hypotheses and research challenges

  2020cites this paper
• Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders

  2020cites this paper
• Impairment of methylglyoxal detoxification systems causes mitochondrial dysfunction and schizophrenia-like behavioral deficits

  2020cites this paper
• The utility of screening for pyridoxine deficiency in a first episode of psychosis.

  2020cites this paper
• Lifestyle and Well-Being: Potential Epigenetic Benefits of Mindfulness Training, Healthy Eating and Physical Activity

  2019cites this paper
• Enhanced Molecular Appreciation of Psychiatric Disorders Through High-Dimensionality Data Acquisition and Analytics.

  2019cites this paper
• Psychiatric Disorders: Methods and Protocols

  2019cites this paper
• Mendelian randomisation for nutritional psychiatry.

  2019cites this paper
• Elevated peripheral blood glutamate levels in major depressive disorder

  2018cites this paper